Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aiganym Amanova
Observed names:
A Amanova,
A. Amanova,
Ayganym Amanova
Institution:
West Kazakhstan Marat Ospanov State Medical University
Observed institution:
West Kazakhstan Marat Ospanov State Medical University
ORCID:
0009-0001-9787-7583
Observed ORCID:
0009-0001-9787-7583
OpenAlex ID:
A5144306288
Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan
2023
·
Zhenisgul Tlegenova
, Saule Balmagambetova
, et al.
·
Diagnostics
·
4
PDF
Three-year follow-up of anthracycline-induced cardiotoxicity risk in breast cancer patients using the HFA-ICOS score
2025
·
A Amanova
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
·
1
Cardiotoxicity of Anthracycline-based Chemotherapy in Breast Cancer Patients: A Case Series
2024
·
Zhenisgul Sh. Tlegenova
, Saule K. Balmagambetova
, et al.
·
Медицинский журнал Западного Казахстана
·
1
PDF
STAMP on CKD: What the 2026 ESC/ERA guidelines change in cardiovascular practice?
2026
·
Dana Kuanova
, Saniya Zhanabergen
, et al.
·
Heart Vessels and Transplantation
PDF
Right Ventricular Functional Changes During Predominantly Anthracycline-Containing Cancer Therapy: An Umbrella Review of Echocardiographic Evidence
2026
·
Zhenisgul Tlegenova
, Aiganym Amanova
, et al.
·
Journal of Cardiovascular Development and Disease
Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort
2026
·
Aiganym Amanova
, Bekbolat Zholdin
, et al.
·
Diagnostics
A structured clinical decision support tool for cardiovascular risk stratification and longitudinal monitoring during anthracycline and HER2-targeted therapy
2026
·
Y Kulmukhanov
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
PDF
Risk-stratified changes in left atrial strain during chemotherapy: preliminary data
2026
·
B Zholdin
, A Amanova
, et al.
·
European Heart Journal Supplements
Right ventricular strain dynamics during anthracycline therapy in breast cancer patients stratified by cardiotoxicity risk: preliminary results
2026
·
Z H Tlegenova
, A Amanova
, et al.
·
European Heart Journal Supplements
Endothelial function trajectories during anthracycline chemotherapy by baseline cardiovascular risk: a prospective three-time point study
2026
·
A Amanova
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
The 2025 AHA/ACC and 2024 ESC hypertension guidelines: From blood pressure thresholds to risk trajectories
2026
·
Yerlan Sagymbay
, Aiganym Amanova
, et al.
·
Heart Vessels and Transplantation
PDF
Heart failure in cardio-oncology: Current approaches to diagnosis, prevention, and treatment (a literature review)
2026
·
A. Amanova
, Zh. Tlegenova
, et al.
·
Oncologia i radiologia Kazakhstana
Heart Failure in Cardio-oncology: Current Approaches to Diagnosis, Prevention, and Treatment (a Literature Review)
2026
·
A. Amanova
, Zh. Tlegenova
, et al.
·
Oncologia i radiologia Kazakhstana
From risk stratification to precision care: what is new in the 2025 ESC guidelines for the management of cardiovascular disease and pregnancy
2025
·
Zhenisgul Tlegenova
, Bekbolat Zholdin
, et al.
·
Heart Vessels and Transplantation
PDF
Advances in Conventional Breast Cancer Biomarkers
2025
·
Zhenisgul Tlegenova
, Aiganym Amanova
, et al.
·
West Kazakhstan Biomedicine Journal
Chemotherapy-Induced Endothelial Dysfunction: a Bibliometric Analysis of Research Trends from 1994 to 2024
2025
·
Aiganym Amanova
, Saule K. Balmagambetova
, et al.
·
Journal of Clinical Medicine of Kazakhstan
Show more works
View as search
Works count:
16
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type